Miguel Cantu, M.D. Titles and Appointments Assistant Professor School Medical School Department Pathology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Dr. Miguel Dario Cantu, MD is a hematopathologist and molecular pathologist at the University of Texas Southwestern where he serves as Assistant Professor of Pathology and Hematopathology Course Director for medical school and pathology residency courses at UTSW. Dr. Cantu is a native of the Rio Grande Valley in South Texas. He graduated summa cum laude from the University of Texas Pan-American with a Bachelor of Science in Biology. He completed his medical training at the University of Texas Health Science Center at Houston’s McGovern Medical School with a scholarly concentration in Molecular and Translational Medicine (2012-2016). He completed an Anatomic and Clinical Pathology Residency at New York Presbyterian – Weill Cornell in New York City (2016-2020) where he served as Assistant Chief Resident and Chief Resident of Anatomic Pathology. He pursued additional fellowship training in Hematopathology at New York Presbyterian—Weill Cornell (2020-2021) followed by a Molecular Genetic Pathology fellowship at the University of Texas Southwestern (2021-2022). Dr. Cantu is board certified by the American Board of Pathology in Anatomic and Clinical Pathology, Hematopathology, and Molecular Genetic Pathology. His clinical research interests include the study of the molecular pathogenesis of myeloid and lymphoid neoplasms with a particular interest in immunodeficiency-associated lymphoproliferative disorders. During his training, Dr. Cantu was a 2021 ASCP 40 Under 40 honoree and received the 2022 Pathologist-in-Training Award from the Society for Hematopathology and the Dr. Janet Caldwell Fellow Research Award for his work studying therapy-related myeloid neoplasms. Education Medical School McGovern Medical School at the University of Texas Health Science Center at Houston (2016) Residency New York Presbyterian Hospital - Weill Cornell Medical Center (2020), Anatomic & Clinical Pathology Fellowship New York Presbyterian Hospital - Weill Cornell Medical Center (2021), Hematopathology Fellowship UT Southwestern Medical Center (2022), Molecular Genetics Publications Featured Publications Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohort. Kometas ML, Hoff FW, Hyak J, Irizarry-Gatell V, Marinos Velarde A, Jackson C, Anderson J, Kalkan FN, Ramakrishnan Geethakumari P, Alvarenga Thiebaud J, Chen W, Weinberg OK, Cantu MD, Collins RH, Chung SS, Madanat YF, Leuk Lymphoma 2025 Mar 1-9 Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment. Zheng R, Gagan JR, Botten GA, Koduru P, Weinberg OK, Chen M, Cantu MD, Jaso J, Germans S, Luu HS, Han L, Slone TL, Dickerson KE, John S, Madanat YF, Chung S, Collins R, Marinos A, Fuda F, Chen W, Eur J Haematol 2025 Mar Clinicopathologic and Molecular Characterization of NUP98-Rearranged Acute Leukemias. Sajjan S, Oertling EE, Fuda F, Gagan J, Koduru P, Garcia R, Kwon A, Lin E, Cantu M, Wilson K, Weinberg OK, Chen M, Jaso JM, Slone TL, Truscott J, Thiebaud JA, Chung S, Madanat YF, Chen W, Int J Lab Hematol 2025 Jan Genomic and Clinicopathological Characterization of CRLF2-Rearranged Mixed Phenotype Acute Leukemia. Han L, Zheng R, Fuda F, Cantu MD, Koduru P, Jaso JM, Weinberg O, Germans S, Chen M, Xu J, Chen W, Pediatr Blood Cancer 2025 Jan e31507 RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis. Han L, Koduru P, Cantu M, Fuda F, Chen W, EJHaem 2024 Dec 5 6 1330-1334 Impact of myelodysplasia-related mutations on 2022 European LeukemiaNet genetic risk classification in de novo acute myeloid leukemia with normal karyotype. Shanker S, Hasserjian RP, Madanat Y, Weinberg OK, Cantu MD, Am J Hematol 2024 Oct Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype. Zheng R, Fuda F, Gagan JR, Weinberg OK, Koduru P, Cantu M, Ludwig K, Truscott JM, Collins R, Chung S, Madanat YF, Chen W, Leuk Res Rep 2024 21 100410 Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalities. Weinberg OK, Cantu MD, Gagan J, Madanat YF, Arber DA, Hasserjian RP, EJHaem 2023 Aug 4 3 760-764 Pancytopenia and haematopoietic precursor vacuolisation in an infant: Clues to Pearson syndrome. Driskill JH, Cantu MD, Garcia J, Dickerson KE, Chen W, Br J Haematol 2023 Jul Updates in molecular genetics of therapy-related myeloid neoplasms. Cantu MD, Semin Diagn Pathol 2023 May 40 3 182-186 Results 1-10 of 19 1 2 Next Last
